(S (NP (NN Epilepsy)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (JJ neurological) (NNS disorders)) (VP (VBG affecting) (NP (NP (NP (QP (RB up) (TO to) (CD 1)) (NN %)) (PP (IN of) (NP (NP (DT the) (NN world) (POS 's)) (NN population)))) (CC and) (NP (NP (QP (RB approximately) (CD 2.5) (CD million)) (NNS people)) (PP (IN in) (NP (DT the) (NNP United) (NNPS States)))))))))) (. .))
(S (NP (NP (NNS Seizures)) (PP (IN in) (NP (NP (QP (JJR more) (IN than) (CD 30)) (NN %)) (PP (IN of) (NP (NN epilepsy) (NNS patients)))))) (VP (VBP are) (ADJP (JJ refractory) (PP (TO to) (NP (JJ anti-epileptic) (NNS drugs))))) (. .))
(S (NP (DT An) (JJ important) (JJ biomedical) (NN research) (NN effort)) (VP (VBZ is) (VP (VBN focused) (PP (IN on) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (DT an) (ADJP (NN energy) (NN efficient)) (JJ implantable) (NN device)) (PP (IN for) (NP (NP (DT the) (JJ real-time) (NN control)) (PP (IN of) (NP (NNS seizures))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBP propose) (NP (DT an) (NAC (NAC (NNP Internet) (PP (IN of) (NP (NNP Medical) (NNP Things)))) (PRN (-LRB- -LRB-) (NP (NNP IoMT)) (-RRB- -RRB-))) (VBN based) (JJ automated) (NN seizure) (NN detection) (CC and) (NN drug) (NN delivery) (NN system) (PRN (-LRB- -LRB-) (NP (NNP DDS)) (-RRB- -RRB-)) (PP (IN for) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NNS seizures))))))) (. .))
(S (NP (DT The) (VBN proposed) (NN system)) (VP (MD will) (VP (VP (VB detect) (NP (NNS seizures))) (CC and) (VP (VB inject) (NP (DT a) (ADJP (JJ fast) (JJ acting)) (JJ anti-convulsant) (NN drug)) (PP (IN at) (NP (DT the) (NN onset))) (S (VP (TO to) (VP (VB suppress) (NP (NN seizure) (NN progression)))))))) (. .))
(S (NP (DT The) (NN drug) (NN injection)) (VP (VBZ is) (VP (VBN performed) (PP (IN in) (NP (CD two) (NNS stages))))) (. .))
(S (ADVP (RB Initially)) (, ,) (NP (DT the) (NN seizure) (NN detector)) (VP (VBZ detects) (NP (DT the) (NN seizure)) (PP (IN from) (NP (DT the) (NN electroencephalography) (PRN (-LRB- -LRB-) (NNP EEG) (-RRB- -RRB-)) (NN signal))) (S (VP (VBG using) (NP (NP (DT a) (JJ hyper-synchronous) (JJ signal) (NN detection) (NN circuit)) (CC and) (NP (NP (DT a) (JJ signal) (NN rejection) (NN algorithm)) (PRN (-LRB- -LRB-) (NP (NNP SRA)) (-RRB- -RRB-))))))) (. .))
(S (PP (IN In) (NP (DT the) (JJ second) (NN stage))) (, ,) (NP (DT the) (NN drug)) (VP (VBZ is) (VP (VBN released) (PP (IN in) (NP (DT the) (NN seizure) (VBN onset) (NN area))) (PP (IN upon) (NP (NN seizure) (NN detection))))) (. .))
(S (NP (DT The) (NN design)) (VP (VBD was) (VP (VBN validated) (S (VP (VBG using) (NP (NP (DT a) (JJ system-level) (NN simulation)) (CC and) (NP (NP (NN consumer) (NNS electronics) (NN proof)) (PP (IN of) (NP (NN concept))))))))) (. .))
(S (NP (DT The) (VBN proposed) (NN seizure) (NN detector)) (VP (VBZ reports) (NP (NP (NP (DT a) (NN sensitivity)) (PP (IN of) (NP (CD 96.9) (NN %)))) (CC and) (NP (NP (NN specificity)) (PP (IN of) (NP (CD 97.5) (NN %)))))) (. .))
(S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (JJ minimal) (NN circuitry)))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT a) (JJ considerable) (NN reduction)) (PP (IN of) (NP (NN power) (NN consumption))) (PP (VBN compared) (PP (TO to) (NP (JJ previous) (NNS approaches))))))) (. .))
(S (NP (DT The) (VBN proposed) (NN approach)) (VP (MD can) (VP (VB be) (VP (VBN generalized) (PP (TO to) (NP (NP (JJ other) (NN sensor) (NNS modalities)) (CC and) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (ADJP (DT both) (JJ wearable) (CC and) (JJ implantable)) (NNS solutions)) (, ,) (CC or) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (DT the) (CD two)))))))))))) (. .))
